Inactive Instrument

Kun Run Biotechnology, Inc. Share Price

Equities

Duration

Period

Style

KUN RUN BIOTCH : Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State Food and Drug Administration	17/10/17	PR
KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Executes Purchase Agreements for Approximately $8 Million Private Placement	22/10/22	PR
KUN RUN BIOTCH : Kun Run Biotechnology Reports Fourth Quarter and Fiscal Year 2009 Financial Results	30/10/30	PR
KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results	13/09/13	PR
KUN RUN BIOTECHNLG : Kun Run Biotechnology, Inc. Year-End Revenues Increase 56% to $11.6 million	01/09/01	PR

Sector

	1st Jan change	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.62%	43.34B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.96B
SANDOZ GROUP AG	+10.86%	14.09B
CIPLA LIMITED	+13.07%	13.64B
ZYDUS LIFESCIENCES LIMITED	+37.46%	11.43B
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.86B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.46%	5.22B